Contact
your House Representative and ask
him or her
to co-sponsor the Genetically Engineered
Food Right to Know Act of 2003 and related bills
that deal with genetically engineered foods.
Representative
Dennis Kucinich (D-OH) has introduced the Genetically
Engineered Food Right to Know Act, HR 2916, before
the U.S. House of Representatives. It is one of
six bills he introduced that regulate genetically
engineered foods (see summaries below).
Congressman
Kucinich has asked us to contact our House Representative
to encourage him or her to co-sponsor the legislation.
Please send an e-mail to your House
Representative and follow that up with a form
letter. Letters mailed have much more impact
than e-mail.
Summary
of Genetically
Engineered Food Legislation
Genetic engineering, the ability to insert a
novel gene in an organism, is a developing science
that offers possible benefits and hazards. Genetic
engineering is defined as something that has
been altered at the molecular or cellular level
by means that are not possible under natural
conditions or processes. This technology is totally
different from traditional breeding techniques.
Genetic engineering is a powerful technology.
The ability to insert any gene into any organism
breaks natural barriers and creates new ethical
quandaries.
Genetic engineering is having a serious impact
on the food we eat, on the environment, and on
farmers. To ensure we can maximize benefits and
minimize hazards, Congress must provide a comprehensive
regulatory framework for all genetically engineered
products (plants, animals, bacteria, and other
organisms).
Current laws, such as our food safety and environmental
laws, were not written with this technology in
mind. These laws were not structured to deal
with a new paradigm created by the novel scientific
capabilities made available by genetic engineering.
Therefore clearer laws are necessary to ensure
that these new scientific capabilities and the
associated impacts are closely monitored.
The
Genetically Engineered Food Right To Know Act
of 2003 - HR 2916
Consumers
wish to know whether the food they purchase
and consume is a genetically engineered food.
Concerns include the potential transfer of
allergens into food and other health risks,
potential environmental risks associated with
the genetic engineering of crops, and religiously
and ethically based dietary restrictions. Consumers
have a right to know whether the food they
purchase contains or was produced with genetically
engineered material. There is also a strong
scientific rationale for mandatory labeling.
It provides an opportunity for continual postmarket
monitoring, allowing for the study of long-term
health impacts. Adoption and implementation
of mandatory labeling requirements for genetically
engineered food produced in the United States
would facilitate international trade. It would
allow American farmers and companies to export
and appropriately market their products—both
genetically engineered and non-genetically
engineered— to foreign customers.
This
bill acknowledges consumers have a right to
know what genetically engineered foods they
are eating:
1.
Requires food companies to label all foods that
contain or are produced with genetically engineered
material.
2. Requires the FDA to periodically test products
to ensure compliance. (A threshold of 1% is established
for accidental contamination.)
3. Voluntary, non-GE food labels are authorized.
4. A legal framework is established to ensure
the accuracy of labeling without creating significant
economic hardship on the food production system.
The
Genetically Engineered Food Safety Act
of 2003 - HR 2917
Genetically
engineered foods present new issues of food safety.
Given the consensus among the scientific community
that genetic engineering can potentially introduce
hazards, such as allergens or toxins, genetically
engineered foods need to be evaluated on a case-by-case
basis and cannot be presumed to be generally recognized
as safe. The possibility of such hazards dictate
a cautious approach to genetically engineered
food approvals. However, FDA has glossed over
the food safety concerns of genetically engineered
foods and not taken steps to ensure the safety
of these genetically engineered foods.
This
bill requires that all genetically engineered
foods follow a strenuous food safety review process:
1.
Requires all genetically engineered foods to follow
FDA’s current food additive process to ensure
they are safe for human consumption.
2. Requires that unique concerns of genetically
engineered foods are explicitly examined in the
review process, a phase out of antibiotic resistance
markers, and a prohibition on known allergens.
3. Continues FDA discretion in the food additive
process in applying the safety factors that are
generally recognized as appropriate.
4. Requires the FDA to conduct a public comment
period of at least 30 days once the completed
safety application is available to the public.
5. The FDA is authorized to contract out for independent
testing of a genetically engineered food and to
seek input on the food safety process from the
National Academy’s Institute of Medicine.
The
Genetically Engineered Crop and Animal Farmer
Protection Act of 2003 - HR 2918
Agribusiness
and biotechnology companies have rapidly consolidated
market power at the same
time as the average farmer’s profits and
viability have significantly declined. Policies
promoted by biotech corporations have systematically
acted to remove basic farmer rights enjoyed since
the beginning of agriculture. These policies
include unreasonable seed contracts, the intrusion
into everyday farm operations, and liability
burdens. The introduction of genetically engineered
crops has also created obstacles for farmers,
including the loss of markets and increased liability
concerns. To mitigate the abuses upon farmers,
a clear set of farmer rights must be established.
Farmer Bill of Rights
This bill provides several farmer rights and
protections to maintain the opportunity to farm:
1. Farmers may save seeds and seek compensation
from biotech companies for failed genetically
engineered crops.
2. Biotech companies may not shift liability
to farmers, nor require access to farmer’s
property, nor mandate arbitration, nor mandate
court of jurisdiction, nor require damages
beyond actual fees, or any other unfair condition.
3. Farmers must be informed of the risks of
using genetically engineered crops.
4. Biotech companies may not charge more to
American farmers for use of this technology,
than they charge farmers in other nations.
5. Seed companies must ensure seeds labeled
non-GE are accurate and provide clear instructions
to reduce cross pollination, which contaminates
other fields.
6. The EPA is required to evaluate the concern
of Bt resistant pests and take actions necessary
to prevent resistance to Bt, an important organic
pesticide.
7. The bill prohibits genetic engineering designed
to produce sterile seeds.
8. The bill prohibits loan discrimination based
on the choice of seeds an agricultural producer
uses.
The
Genetically Engineered Organism Liability Act
of 2003 - HR 2919
The
negative consequences of genetically engineered
crops may impact farmers who grow these crops,
neighboring farmers who do not grow these crops,
as well as consumers. Biotech companies are selling
a technology that is being commercialized far
in advance of the new and unknown science of
genetic engineering. Farmers may suffer from
crop failures, neighboring farmers may suffer
from cross pollination, increased insect resistance,
and unwanted “volunteer” genetically
engineered plants, and consumers may suffer from
health and environmental impacts. Therefore,
biotech companies should be found liable for
the failures of genetically engineered crops.
This bill ensures that the creator of the technology
assumes the liability resulting from the technology.
1.
The bill places all liability from negative impacts
of genetically engineered organisms squarely upon
the biotechnology companies that created the genetically
engineered organism.
2. Farmers are granted indemnification to protect
them from the liabilities of biotech companies.
3. The bill prohibits any transfer of liability
away from the biotechnology companies that created
the genetically engineered organism.
Real
Solutions to World Hunger Act of 2003 - HR 2920
The
demand for mandatory labeling, safety testing,
and farmer protections do not constitute obstacles
to the cessation of world hunger. Technologies,
like genetically engineered food, may have a
limited role, but economics remain the significant
barrier to a consistent food supply, and the
development of expensive genetically engineered
foods may only exacerbate this trend. Most genetically
engineered food products and almost all research
funding for the development of genetically engineered
food target the developed nation’s agriculture
and consumers. Developing countries cannot afford
this technology and therefore are vastly ignored.
Agroecological interventions have had significantly
more success in helping developing nations feed
themselves with higher yields and improved environmental
practices, all within reasonable costs for developing
countries. If the biotech industry believes they
can help mitigate hunger concerns, domestic or
foreign, then requiring them to fund the effort
to mitigate hunger is appropriate.
This bill offers several new initiatives and
protections to help developing nations resolve
their hunger concerns:
1. To protect developing nations, genetically
engineered exports are restricted to those already
approved in the U.S. and approved by the importing
nation.
2. The bill creates an international research
fund for sustainable agriculture research.
3. A developing nation may choose to mandatorily
license a genetically engineered crop for the
benefit of its citizens. The bill prohibits any
U.S. intervention that may block the mandatory
license.
4. The bill establishes the Sustainable Agriculture
Trust Fund with a small tax on biotechnology
company profits. This trust fund will fund the
activities in this bill.
The
Genetically Engineered Pharmaceutical and Industrial
Crop Safety Act of 2003 - HR 2921
A pharmaceutical crop or industrial crop is
a plant that has been genetically engineered
to produce a medical or industrial product, including
human or veterinary drugs, biologic, industrial,
or research chemicals, or enzymes. Weak USDA
regulations have already permitted the cultivation
of over 300 open-air field trials. Many of the
novel substances produced in pharmaceutical crops
and industrial crops are for particular medical
or industrial purposes only. These substances
are not intended to be incorporated in food or
to be spread into the environment. That would
be equivalent to allowing a prescription drug
in the food supply.
Currently, contamination is prevalent in our
food system. Crops like corn cross-pollinate
in the field over several miles and grain-handling
systems are capable of commingling a commodity.
Experts acknowledge that contamination of human
food and animal feed is inevitable due to the
inherent imprecision of biological and agricultural
systems. This contamination by pharmaceutical
crops and industrial crops pose substantial liability
and other economic risks to farmers, grain handlers,
and food companies. These risks include liability
for contamination episodes, costly food recalls,
losses in export markets, reduced prices for
a contaminated food or feed crop, and loss of
confidence in the safety of the American food
supply among foreign importers and consumers
of American agricultural commodities.
This bill attempts to prevent contamination
of our food supply by pharmaceutical crops and
industrial crops.
1. The bill places a temporary moratorium on
pharmaceutical crops and industrial crops until
all regulations required in this bill are in
effect.
2. The bill places a permanent moratorium on
pharmaceutical crops and industrial crops grown
in an open-air environment.
3. The bill places a permanent moratorium on
pharmaceutical crops and industrial crops grown
in a commonly used food source.
4. The United States Department of Agriculture
shall establish a tracking system to regulate
the growing, handling, transportation, and disposal
of all pharmaceutical and industrial crops and
their byproducts to prevent contamination.
5. The National Academy of Sciences shall submit
to Congress a report that explores alternatives
methods to produce pharmaceuticals or industrial
chemicals that have the advantage of being conducted
in controlled production facilities and do not
present the risk of contamination.
For
more information on these bills, please contact
the office of
Representative Dennis Kucinich at (202) 225-5871.
|